Document is current
Any future updates will be listed below
-
Authors
Coulibaly, Boubacar
Sié, Ali
Dah, Clarisse
Bountogo, Mamadou
Ouattara, Mamadou
Compaoré, Adama
Nikiema, Moustapha
Tiansi, Jérôme Nankoné
Sibiri, Nestor Dembélé
Brogdon, Jessica M.
Lebas, Elodie
Doan, Thuy
Porco, Travis C.
Lietman, Thomas M.
Oldenburg, Catherine E. https://orcid.org/0000-0002-0763-399X
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03676751 at ClinicalTrials.govDocuments that mention this clinical trial
Neonatal azithromycin administration to prevent infant mortality: study protocol for a randomised controlled trial
https://doi.org/10.1136/bmjopen-2019-031162
Mass azithromycin administration: considerations in an increasingly resistant world
https://doi.org/10.1136/bmjgh-2020-002446
Effect of a single dose of oral azithromycin on malaria parasitaemia in children: a randomized controlled trial
https://doi.org/10.1186/s12936-021-03895-9
-
Funding
Funding for this research was provided by:
Bill and Melinda Gates Foundation (OPP1187628)
Research to Prevent Blindness (Research to Prevent Blindness)
- License Information
-
More Information
Article History
Received: 9 March 2021
Accepted: 25 August 2021
First Online: 31 August 2021
Declarations
:
: This study was reviewed and approved by the Institutional Review Board at the University of California, San Francisco and the Comité National d’Ethique pour la Recherche (National Ethics Committee of Burkina Faso) in Ouagadougou, Burkina Faso. Written informed consent was obtained from the caregiver of each enrolled participant. All study procedures were conducted in accordance with the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.
